Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples;Molekulare diagnostik in der urologischen onkologie: Detektion von nukleinsäuren in urinproben

Urologe - Ausgabe A

Volumn 42, Issue 5, 2003, Pages 660-668

  Muller M ^a   Goessl, C ^b   Krause, H ^a   Miller, K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Bladder cancer; Molecular diagnostics; Prostate cancer; Renal cell carcinoma; Urine samples

Indexed keywords

DNA; NUCLEIC ACID; TUMOR MARKER;

BIOTECHNOLOGY; BLADDER CANCER; BLOOD SAMPLING; CANCER DIAGNOSIS; DEGRADATION; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MOLECULAR BIOLOGY; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROTEIN URINE LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR CELL; URINALYSIS; UROTHELIUM;

EID: 0038509093     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-003-0350-3     Document Type: Review

References (37)

1. Adam BL, Vlahou A, Semmes OJ, Wright GL, Jr. (2001) Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics 1:1264-1270
2. Arai Y, Yajima T, Yagihashi A et al.(2000) Limitations of urinary telomerase activity measurement in urothelial cancer. Clin Chim Acta 296:35-44
3. Bialkowska-Hobrzanska H, Bowles L, Bukala B et al. (2000) Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma. Mol Diagn 5:267-277
4. Botezatu I, Serdyuk O, Potapova G et al. (2000) Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem 46:1078-1084
5. Brooks JD, Weinstein M, Lin X et al. (1998) CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 7:531-536
6. Cairns P, Esteller M, Herman JG et al. (2001) Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res 7:2727-2730
7. Cassel A, Rahat MA, Lahat N et al. (2OO1) Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise, 166:841-844
8. Chan MW, Chan LW, Tang NL et al. (2002) Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. Clin Cancer Res 8: 464-470
9. de Kok JB, Ruers TJ, van Muijen GN et al. (2000) Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Clin Chem 46: 313-318
10. Eisenberger CF, Schoenberg M, Enger C et al. (1999) Diagnosis of renal cancer by molecular urinalysis. J Natl Cancer Inst 91:2028-2032
11. Fitzgerald JM, Ramchurren N, Rieger K et al. (1995) Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. J Natl Cancer Inst 87:129-133
12. Fliss MS, Usadel H, Caballero OL et al.(2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017-2019
13. Friedrich MG, Erbersdobler A, Schwaibold H et al. (2000) Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer. J Urol 163:1039-1042
14. Goessl C, Heicappell R, Munker R et al. (1998) Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res 58:4728-4732
15. Goessl C, Krause H, Müller M et al. (2000) Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res 60:5941-5945
16. Goessl C, Müller M, Heicappell R, Krause H, Miller K (2001) DNA-based detection of prostate cancer in blood, urine, and ejaculates. Ann NY Acad Sci 945: 51-58
17. Goessl C, Müller M, Heicappell R et al. (2002) Methylation-specific PCR for detection of neoplastic DNA in biopsy washings. J Pathol 196:331-334
18. Goessl C, Müller M, Heicappell R et al. (2001) DNA-based detection of prostate cancer in urine after prostatic massage. Urology 58:335-338
19. Ito H, Kyo S, KanayaT et al. (1998) Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Clin Cancer Res 4:2807-2810
20. Jeronimo C, Nomoto S, Caballero OL et al. (2001) Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20:5195-5198
21. Lee WH, Isaacs WB, Bova GS, Nelson WG (1997) CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 6:443-450
22. Lee WH, Morton RA, Epstein JI et al. (1994) Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A 91: 11733-11737
23. Lokeshwar VB, Soloway MS (2001) Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol 16S:1067-1077
24. Mao L, Schoenberg MP, Seicchitano M et al. (1996) Molecular detection of primary bladder cancer by microsatellite analysis. Science 271:659-662
25. Marusic A (2001) DNA lab helps identify missing persons in Croatia and Bosnia and Herzegovina. Lancet 358:1244
26. Meid FH, Gygi CM, Leisinger HJ, Bosman FT, Benhattar J (2001) The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage. J Urol 165:1802-1805
27. Müller M (2002) Telomerase: its clinical relevance in the diagnosis of bladder cancer. Oncogene 21:650-655
28. Müller M, Heine B, Heicappell R et al. (1996) Telomerase activity in bladder cancer, bladder washings and in urine. 9:1169-1173
29. Papanicolaou GN, Marshall VF (1945) Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 101:519-523
30. Plass C (2002) Cancer epigenomics. Hum Mol Genet 11: 2479-2488
31. Serdyuk OI, Botezatu IV, Shelepov VP et al. (2001) Detection of mutant k-ras sequences in the urine of cancer patients. Bull Exp Biol Med 131:283-284
32. Sidransky D (1997) Nucleic acid-based methods for the detection of cancer. Science 278:1054-1059
33. Sidransky D, Von Eschenbach A, Tsai YC et al. (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706-709
34. Steiner G, Reinschmidt G, Muller SC (1999) Molecular genetic diagnosis of de novo and recurrent bladder cancer. Electrophoresis 20:280-282
35. van Rhijn BW, Lurkin I, Kirkels WJ, van der Kwast TH, Zwarthoff EC (2001) Microsatellite analysis - DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial. Cancer 92:768-775
36. von Knobloch R, Hegele A, Brandt H et al. (2002) High frequency of serum DNA alterations in renal cell carcinoma detected by fluorescent microsatellite analysis. Int J Cancer 98:889-894
37. Wu YY, Hruszkewycz AM, Delgado RM et al.(2000) Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. Clin Chim Acta 293:199-212